Granulocyte Cytoplasmic Antigens in Renal Vasculitis

Arnaout, M. Amin

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Research Project (R01)
• Project #: 5R01DK042722-06
• Application #: 2142505
• Study Section: Pathology A Study Section (PTHA)
• Project Start: 1990-05-01
• Project End: 1999-04-30
• Budget Start: 1996-05-01
• Budget End: 1997-04-30
• Support Year: 6
• Fiscal Year: 1996

Institution

• Name: Massachusetts General Hospital
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02199

Publications

Goldmann, W H; Niles, J L; Arnaout, M A (1999) Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur J Biochem 261:155-62

Daouk, G H; Palsson, R; Arnaout, M A (1995) Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 47:1528-36

Fienberg, R; Mark, E J; Goodman, M et al. (1993) Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 24:160-8

Bottinger, E P; Niles, J L; Collins, A B et al. (1992) Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjogren's syndrome. Arthritis Rheum 35:1373-6